These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26803330)
1. Influenza B Burden in Latin America and Potential Benefits of the New Quadrivalent Vaccines. Falleiros Arlant LH; Bricks LF J Pediatric Infect Dis Soc; 2016 Mar; 5(1):1-2. PubMed ID: 26803330 [No Abstract] [Full Text] [Related]
3. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Ray R; Dos Santos G; Buck PO; Claeys C; Matias G; Innis BL; Bekkat-Berkani R Hum Vaccin Immunother; 2017 Jul; 13(7):1640-1652. PubMed ID: 28532276 [TBL] [Abstract][Full Text] [Related]
4. New options for influenza vaccines: quadrivalent, recombinant, and cell culture. Brokhof MM; Foster SL; Hayney MS J Am Pharm Assoc (2003); 2013; 53(5):545-9. PubMed ID: 24030133 [No Abstract] [Full Text] [Related]
12. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1992-93 season. Can Commun Dis Rep; 1992 May; 18(10):73-8. PubMed ID: 1284383 [No Abstract] [Full Text] [Related]
13. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1994-95 season. Can Commun Dis Rep; 1994 Jun; 20(11):85-92. PubMed ID: 7522728 [No Abstract] [Full Text] [Related]
14. Recommended composition of influenza virus vaccines for use in the 1990-1991 season. Wkly Epidemiol Rec; 1990 Feb; 65(8):53-6. PubMed ID: 2386721 [No Abstract] [Full Text] [Related]